



@article {2311,
	title = {NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target},
	journal = {Current Drug TargetsCurr. Drug Targets},
	volume = {10},
	year = {2009},
	note = {Cited By (since 1996): 5Export Date: 21 November 2012Source: ScopusCODEN: CDTUAdoi: 10.2174/138945009787122888Language of Original Document: EnglishCorrespondence Address: Lamghari, M.; INEB - Instituto de Engenharia Biom{\'e}dica, Universidade do Porto, NEWTherapies Group, Rua do Campo Alegre 823, 4150-180 Porto, Portugal; email: lamghari@ineb.up.ptChemicals/CAS: gr 231118, 158859-98-4; n [1 [4 [[[[4 [(dimethylamino)methyl]cyclohexyl]methyl]amino]iminomethyl]benzyl] 2 oxo 2 (1 pyrrolidinyl)ethyl] alpha [(2 naphthalenylsulfonyl)amino]benzenepropanamide, 163238-19-5; n2 diphenylacetyl n (4 ureidomethylbenzyl)argininamide, 191868-14-1, 217977-06-5; nalpha (diphenylacetyl) n (4 hydroxybenzyl) dextro argininamide, 159013-54-4; neuropeptide Y, 82785-45-3, 83589-17-7; peptide YY, 81858-94-8; Ligands; Neuropeptide Y; Receptors, Neuropeptide YTradenames: bibo 3304; bibp 3226; gi 264879a; gr 231118; gw 1229; j 115814; ly 357897; sr 120819aReferences: Lundberg, P., Lerner, U.H., (2002) Microsc. Res. Tech, 58 (2), pp. 98-103;Baldock, P.A., Sainsbury, A., Couzens, M., Enriquez, R.F., Thomas, G.P., Gardiner, E.M., Herzog, H., (2002) J. Clin. Invest, 109 (7), pp. 915-921; 
Baldock, P.A., Allison, S., McDonald, M.M., Sainsbury, A., Enriquez, R.F., Little, D.G., Eisman, J.A., Herzog, H., (2006) J. Bone Miner. Res, 21 (10), pp. 1600-1607; 
Tatemoto, K., Carlquist, M., Mutt, V., (1982) Nature, 296 (5858), pp. 659-660; 
Tatemoto, K., (1982) Proc. Natl. Acad. Sci. U.S.A, 79 (18), pp. 5485-5489; 
Larhammar, D., (1996) Regul. Pept, 62, pp. 1-11; 
Tatemoto, K., (1982) Proc. Natl. Acad. Sci. U.S.A, 79 (8), pp. 2514-2518; 
Kimmel, J.R., Hayden, J., Pollock, H.G., (1975) J. Biol. Chem, 250 (24), pp. 9369-9376; 
Michel, M.C., Beck-Sickinger, A., Cox, H., Doods, H.N., Herzog, H., Larhammar, D., Quirion, R., Westfall, T., (1998) Pharmacol. Rev, 50 (1), pp. 143-150; 
Fuhlendorff, J., Johansen, N.L., Melberg, S.G., Thogersen, H., And Schwartz, T.W., (1990) J. Biol. Chem, 265 (20), pp. 11706-11712; 
Blundell, T.L., Pitts, J.E., Tickle, I.J., Wood, S.P., Wu, C.W., (1981) Proc. Natl. Acad. Sci. U.S.A, 78 (7), pp. 4175-4179; 
Cerd{\'a}-Reverter, J., Larhammar, D., (2000) Biochem. Cell Biol, 78 (3), pp. 371-392; 
Allen, J., Novotn{\'y}, J., Martin, J., Heinrich, G., (1987) Proc. Natl. Acad. Sci. U.S A, 84 (8), pp. 2532-2536; 
Wan, C.P., Lau, B.H.S., (1995) Life Sci, 56 (13), pp. 1055-1064; 
Schwartz, T.W., Fuhlendorff, J., Kjems, L.L., Kristensen, M.S., Vervelde, M., O{\textquoteright}Hare, M., Krstenansky, J.L., Bjornholm, B., (1990) Ann. N.Y. Acad. Sci, 611, pp. 35-47; 
Nordmann, A., Blommers, M.J.J., Fretz, H., Arvinte, T., Drake, A.F., (1999) Eur. J. Biochem, 261 (1), pp. 216-226; 
Minth, C.D., Bloom, S.R., Polak, J.M., Dixon, J.E., (1984) Proc. Natl. Acad. Sci. U.S.A, 81 (14), pp. 4577-4581; 
Chronwall, B.M., DiMaggio, D.A., Massari, V.J., Pickel, V.M., Ruggiero, D.A., O{\textquoteright}Donohue, T.L., (1985) Neuroscience, 15 (4), pp. 1159-1181; 
Wai, S.M., Kindler, P.M., Lam, E.T., Zhang, A., Yew, D.T., (2004) Cell Mol. Neurobiol, 24 (5), pp. 667-684; 
Sundler, F., B{\"o}ttcher, G., Ekblad, E., Hakanson, R., (1993) The Biology of Neuropeptide Y and Related Peptides, pp. 157-196. , Colmers, W.F. and Wahlestedt, C, Ed, Humana Press, New Jersey, pp; 
Ekblad, E., Hakanson, R., Sundler, F., (1984) Regul. Pept, 10 (1), pp. 47-55; 
Cavadas, C., Silva, A.P., Mosimann, F., Cotrim, M.D., Ribeiro, C.A.F., Brunner, H.R., Grouzmann, E., (2001) J. Clin. Endocrinol. Metab, 86 (12), pp. 5956-5963; 
Silva, A.P., Cavadas, C., Grouzmann, E., (2002) Clin. Chim. Acta, 326 (1-2), pp. 3-25; 
Strand, F.L., (1999) Neuropeptides: Regulators of Physiological Processes, , MIT Press: Cambridge; 
Ericsson, A., Schalling, M., McIntrye, K.R., Lundberg, J.M., Larhammar, D., Seroogy, K., Hokfelt, T., Persson, H., (1987) Proc. Natl. Acad. Sci. U.S.A, 84 (16), pp. 5585-5589; 
Yang, K., Guan, H., Arany, E., Hill, D.J., Cao, X., (2008) FASEB J, 22 (7), pp. 2452-2464; 
Pedrazzini, T., Pralong, F., Grouzmann, E., (2003) Cell Mol. Life Sci, 60 (2), pp. 350-377; 
Blomqvist, A.G., Herzog, H., (1997) Trends Neurosci, 20 (7), pp. 294-298; 
Berglund, M.M., Schober, D.A., Statnick, M.A., McDonald, P.H., Gehlert, D.R., (2003) J. Pharmacol. Exp. Ther, 306 (1), pp. 147-156; 
Berglund, M., Hipskind, P., Gehlert, D., (2005) NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis and Cancer, pp. 29-62. , Zukowska, Z. and Feuerstein, G.Z, Ed, Birkhaeuser Verlag, Switzerland, pp; 
Larhammar, D., Salaneck, E., (2004) Neuropeptides, 38 (4), pp. 141-151; 
Gregor, P., Feng, Y., DeCarr, L.B., Cornfield, L.J., McCaleb, M.L., (1996) J. Biol. Chem, 271 (44), pp. 27776-27781; 
Starb{\"a}ck, P., Wraith, A., Eriksson, H., Larhammar, D., (2000) Biochem. Biophys. Res. Commun, 277 (1), pp. 264-269; 
Wraith, A., T{\"o}rnsten, A., Chardon, P., Harbitz, I., Chowdhary, B.P., Andersson, L., Lundin, L.G., Larhammar, D., (2000) Genome Res, 10 (3), pp. 302-310; 
Larhammar, D., Wraith, A., Berglund, M.M., Holmberg, S.K.S., Lundell, I., (2001) Peptides, 22 (3), pp. 295-307; 
Larhammar, D., Blomqvist, A., Yee, F., Jazin, E., Yoo, H., Wahlested, C., (1992) Proc. Natl. Acad. Sci. U.S.A, 267 (16), pp. 10935-10938; 
Herzog, H., Hort, Y.J., Ball, H.J., Hayes, G., Shine, J., Selbie, L.A., (1992) Proc. Natl. Acad. Sci. U.S.A, 89 (13), pp. 5794-5798; 
Mullins, D.E., Zhang, X., Hawes, B.E., (2002) Regul. Pept, 105 (1), pp. 65-73; 
Krause, J., Eva, C., Seeburg, P.H., Sprengel, R., (1992) Mol. Pharmacol, 41 (5), pp. 817-821; 
Eva, C., Keinanen, K., Monyer, H., Seeburg, P., Sprengel, R., (1990) FEBS J, 271 (1-2), pp. 81-84; 
Nakamura, M., Sakanaka, C., Aoki, Y., Ogasawara, H., Tsuji, T., Kodama, H., Matsumoto, T., Noma, M., (1995) J. Biol. Chem, 270 (50), pp. 30102-30110; 
{\'A}lvaro, A.R., Martins, J., Ara{\'u}jo, I.M., Rosmaninho-Salgado, J., Ambr{\'o}sio, A.F., Cavadas, C., (2008) J. Neurochem, , Epub ahead of print; 
Herzog, H., Baumgartner, M., Vivero, C., Selbie, L.A., Auer, B., Shine, J., (1993) J. Biol. Chem, 268 (9), pp. 6703-6707; 
Marklund, U., Bystr{\"o}m, M., Gedda, K., Larefalk, A., Juneblad, K., Nystr{\"o}m, S., Ekstrand, A.J., (2002) Mol. Cell Endocrinol, 188 (1-2), pp. 85-97; 
Ball, H.J., Shine, J., Herzog, H., (1995) J. Biol. Chem, 270 (45), pp. 27272-27276; 
Ferguson, S.S., (2001) Pharmacol. Rev, 53 (1), pp. 1-24; 
Okamoto, T., Schlegel, A., Scherer, P.E., Lisanti, M.P., (1998) J. Biol. Chem, 273 (10), pp. 5419-5422; 
Fabry, M., Langer, M., Rothen-Rutishauser, B., Wunderli-Allenspach, H., H{\"o}cker, H., Beck-Sickinger, A.G., (2000) Eur. J. Biochem, 267 (17), pp. 5631-5637; 
Parker, S.L., Kane, J.K., Parker, M.S., Berglund, M.M., Lundell, I.A., Li, M.D., (2001) Eur. J. Biochem, 268 (4), pp. 877-886; 
Gicquiaux, H., Lecat, S., Gaire, M., Dieterlen, A., M{\'e}ly, Y., Takeda, K., Bucher, B., Galzi, J.L., (2002) J. Biol. Chem, 277 (8), pp. 6645-6655; 
Ouedraogo, M., Lecat, S., Rochdi, M.D., Hachet-Haas, M., Matthes, H., Gicquiaux, H., Verrier, S., Bucher, B., (2008) Traffic, 9 (3), pp. 305-324; 
Holliday, N.D., Lam, C.W., Tough, I.R., Cox, H.M., (2005) Mol. Pharmacol, 67 (3), pp. 655-664; 
Broberger, C., Visser, T.J., Kuhar, M.J., H{\"o}kfelt, T., (1999) Neuroendocrinology, 70 (5), pp. 295-305; 
Kopp, J., Xu, Z.Q., Zhang, X., Pedrazzini, T., Herzog, H., Kresse, A., Wong, H., H{\"o}kfelt, T., (2002) Neurosci, 111 (3), pp. 443-532; 
Larsen, P.J., Tang-Christensen, M., Stidsen, C.E., Madsen, K., Smith, M.S., Cameron, J.L., (1999) J. Clin. Endocrinol. Metab, 84 (10), pp. 3781-3791; 
Wharton, J., Gordon, L., Byrne, J., Herzog, H., Selbie, L.A., Moore, K., Sullivan, M.H., Polak, J.M., (1993) Proc. Natl. Acad. Sci. U.S.A, 90 (2), pp. 687-691; 
Feth, F., Rascher, W., Michel, M.C., (1992) Br. J. Pharmacol, 105 (1), pp. 71-76; 
DiMaggio, D.A., Farah Jr, J.M., Westfall, T.C., (1994) Endocrinology, 134 (2), pp. 719-727; 
Dumont, Y., Quirion, R., (2006) Progress in Inflammation Research, pp. 7-33. , Feuernstein, G. and Zukowska-Grojec, Z, Ed, Birkhaeuser Verlag, Switzerland, pp; 
Balasubramaniam, A., (2003) Curr. Pharm. Des, 9 (15), pp. 1165-1175; 
Fuhlendorff, J., Gether, U., Aakerlund, L., Langeland-Johansen, N., Thogersen, H., Melberg, S.G., Olsen, U.B., Schwartz, T.W., (1990) Proc. Natl. Acad. Sci. U.S.A, 87 (1), pp. 182-186; 
Grandt, D., Feth, F., Rascher, W., Reeve Jr., J.R., Schlicker, E., Schimiczek, M., Layer, P., Michel, M.C., (1994) Eur. J. Pharmacol, 269 (2), pp. 127-132; 
S{\"o}ll, R.M., Dinger, M.C., Lundell, I., Larhammer, D., Beck-Sickinger, A.G., (2001) Eur. J. Biochem, 268 (10), pp. 2828-2837; 
Mullins, D., Kirby, D., Hwa, J., Guzzi, M., Rivier, J., Parker, E., (2001) Mol. Pharmacol, 60 (3), pp. 534-540; 
Rudolf, K., Eberlein, W., Engel, W., Wieland, H.A., Willim, K.D., Entzeroth, M., Wienen, W., Doods, H.N., (1994) Eur. J. Pharmacol, 271 (2-3), pp. R11-R13; 
Wieland, H.A., Engel, W., Eberlein, W., Rudolf, K., Doods, H.N., (1998) Br. J. Pharmacol, 125 (3), pp. 549-555; 
Daniels, A.J., Matthews, J.E., Slepetis, R.J., Jansen, M., Viveros, O.H., Tadepalli, A., Harrington, W., Spaltenstein, A., (1995) Proc. Natl. Acad. Sci. U.S.A, 92 (20), pp. 9067-9071; 
Schober, D.A., Van Abbema, A.M., Smiley, D.L., Bruns, R.F., Gehlert, D.R., (1998) Peptides, 19 (3), pp. 537-542; 
Balasubramaniam, A., Dhawan, V.C., Mullins, D.E., Chance, W.T., Sheriff, S., Guzzi, M., Prabhakaran, M., Parker, E.M., (2001) J. Med. Chem, 44 (10), pp. 1479-1482; 
Daniels, A.J., Chance, W.T., Grizzle, M.K., Heyer, D., Matthews, J.E., (2001) Peptides, 22 (3), pp. 483-491; 
Hipskind, P.A., Lobb, K.L., Nixon, J.A., Britton, T.C., Bruns, R.F., Catlow, J., Dieckman-McGinty, D.K., Gehlert, D.R., (1997) J. Med. Chem, 40 (23), pp. 3712-3714; 
Schneider, E., Keller, M., Brennauer, A., Hoefelschweiger, B.K., Gross, D., Wolfbeis, O.S., Bernhardt, G., Buschauer, A., (2007) ChemBioChem, 8 (16), pp. 1981-1988; 
Serradeil-Le, G.C., Valeet, G., Rouby, P.E., Pellet, A., Oury-Donat, F., Brossard, G., Lespy, L., LeFur, G., (1995) FEBS Lett, 362 (2), pp. 192-196; 
Kanatani, A., Hata, M., Mashiko, S., Ishihara, A., Okamoto, O., Haga, Y., Ohe, T., Ihara, M., (2001) Mol. Pharmacol, 59 (3), pp. 501-505; 
Wahlestedt, C., H{\r a}kanson, R., (1986) Med. Biol, 64 (2-3), pp. 85-88; 
Doods, H.N., Wieland, H.A., Engel, W., Eberlein, W., Willim, K.D., Entzeroth, M., Wienen, W., Rudolf, K., (1996) Regul. Pept, 65 (1), pp. 71-77; 
Gerald, C., Walker, M.W., Criscione, L., Gustafson, E.L., Batzl-Hartmann, C., Smith, K.E., Vaysse, P., Weinshank, R.L., (1996) Nature, 382 (6587), pp. 168-171; 
Lin, S., Boey, D., Herzog, H., (2004) Neuropeptides, 38 (4), pp. 189-200; 
Pedrazzini, T., (2004) Neuropeptides, 38 (4), pp. 267-275; 
Pedrazzini, T., Seydoux, J., K{\"u}nstner, P., Aubert, J.F., Grouzmann, E., Beermann, F., Brunner, H.R., (1998) Nat. Med, 4 (6), pp. 722-726; 
Kushi, A., Sasai, H., Koizumi, H., Takeda, N., Yokoyama, M., Nakamura, M., (1998) Proc. Natl. Acad. Sci. U.S.A, 95 (26), pp. 15659-15664; 
Naveilhan, P., Canals, J.M., Arenas, E., Ernfors, P., (2001) J. Neurochem, 78 (6), pp. 1201-1207; 
Thiele, T.E., Koh, M.T., Pedrazzini, T., (2002) J. Neurosci, 22 (3), pp. RC208-RC214; 
Karlsson, R.M., Choe, J.S., Cameron, H.A., Thorsell, A., Crawley, J.N., Holmes, A., Heilig, M., (2008) Psychopharmacology (Berlin, Ger.), 195 (4), pp. 547-557; 
Wheway, J., Mackay, C.R., Newton, R.A., Sainsbury, A., Boey, D., Herzog, H., Mackay, F., (2005) J. Exp. Med, 202 (11), pp. 1527-1538; 
Zukowska-Grojec, Z., Karwatowska-Prokopczuk, E., Fisher, T.A., Ji, H., (1998) Regul. Pept, 75-76, pp. 231-238; 
Hansel, D.E., Eipper, B.A., Ronnett, G.V., (2001) Nature, 410 (6831), pp. 940-944; 
Howell, O.W., Doyle, K., Goodman, J.H., Scharfman, H.E., Herzog, H., Pringle, A., Beck-Sickinger, A.G., Gray, W.P., (2005) J. Neurochem, 93 (3), pp. 560-570; 
Cho, Y.R., Kim, C.W., (2004) Biochem. Biophys. Res. Commun, 314 (3), pp. 773-780; 
Milenkovic, I., Weick, M., Wiedemann, P., Reichenbach, A., Bringmann, A., (2004) Graefe{\textquoteright}s Arch. Clin. Exp. Ophthalmol, 242 (11), pp. 944-950; 
Anitha, M., Chandrasekharan, B., Salgado, J.R., Grouzmann, E., Mwangi, S., Sitaraman, S.V., Srinivasan, S., (2006) Gastroenterology, 131 (4), pp. 1164-1178; 
Doyle, K.L., Karl, T., Hort, Y., Duffy, L., Shine, J., Herzog, H., (2008) J. Neurochem, 105 (3), pp. 641-652; 
Jacques, D., Abdel-Samad, D., (2007) Can. J. Physiol. Pharmacol, 85 (1), pp. 43-53; 
Agasse, F., Bernardino, L., Kristiansen, H., Christiansen, S.H., Ferreira, R., Silva, B., Grade, S., Malva, J.O., (2008) Stem Cells, 26 (6), pp. 1636-1645; 
Movafagh, S., Hobson, J.P., Spiegel, S., Kleinman, H.K., Zukowska, Z., (2006) FASEB J, 20 (11), pp. 1924-1926; 
Ruscica, M., Dozio, E., Boghossian, S., Bovo, G., Ria{\~n}o, V.M., Motta, M., Magni, P., (2006) Endocrinology, 147 (3), pp. 1466-1473; 
Seger, R., Krebs, E.G., (1995) FASEB J, 9 (9), pp. 726-735; 
Kholodenko, B.N., (2002) Trends Cell Biol, 12 (4), pp. 173-177; 
Eva, C., Serra, M., Mele, P., Panzica, G.C., Oberto, A., (2006) Front. Neuroendocrinol, 27 (3), pp. 308-339; 
Elefteriou, F., Bone Cell Mol (2005) Life Sci, 62 (19-20), pp. 2339-2349; 
Chenu, C., (2004) J. Musculoskcl. Neuron. Interact, 4 (2), pp. 132-134; 
Allison, S.J., Baldock, P.A., Herzog, H., (2007) Peptides, 28 (2), pp. 320-325; 
Bjurholm, A., Kreicbergs, A., Terenius, L., Goldstein, M., Schultzberg, M., (1988) J. Auton. Nerv. Syst, 25 (2-3), pp. 119-125; 
Hill, E.L., Elde, R., (1991) Cell Tissue Res, 264 (3), pp. 469-480; 
Ahmad, T., Ugarph-Morawski, A., Li, J., Bileviciute-Ljungar, I., Finn, A., Ostenson, C.G., Kreicbergs, A., (2004) Regul. Pept, 119 (1-2), pp. 61-67; 
Togari, A., Arai, M., Mizutani, S., Mizutani, S., Koshihara, Y., Nagatsu, T., (1997) Neurosci. Lett, 233 (2-3), pp. 125-128; 
Lundberg, P., Allison, S.J., Lee, N.J., Baldock, P.A., Brouard, N., Rost, S., Enriquez, R.F., Herzog, H., (2007) J. Biol. Chem, 282 (26), pp. 19082-19091; 
Baldock, P.A., Sainsbury, A., Allison, S., Lin, E.J., Couzens, M., Boey, D., Enriquez, R., Gardiner, E.M., (2005) J. Bone Miner. Res, 20 (10), pp. 1851-1857; 
Ducy, P., Schinke, T., Karsenty, G., (2000) Science, 289 (5484), pp. 1501-1504; 
Takeda, S., Karsenty, G., (2001) J. Bone Miner. Metab, 19 (3), pp. 195-198; 
Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A.F., Beil, F.T., Shen, J., Karsenty, G., (2000) Cell, 100 (2), pp. 197-207; 
Stephens, T.W., Basinski, M., Bristow, P.K., Bue-Valleskey, J.M., Burgett, S.G., Craft, L., Hale, J., Heiman, M., (1995) Nature, 377 (6549), pp. 530-532; 
Erickson, J.C., Hollopeter, G., Palmiter, R.D., (1996) Science, 274 (5293), pp. 1704-1707; 
Allison, S.J., Baldock, P., Sainsbury, A., Enriquez, R., Lee, N.J., Lin, E.J., Klugmann, M., Gardiner, E.M., (2006) J. Biol. Chem, 281 (33), pp. 23436-23444; 
Bjurholm, A., Kreicbergs, A., Schultzberg, M., Lerner, U.H., (1992) J. Bone Miner. Res, 7 (9), pp. 1011-1019; 
Bjurholm, A., Kreicbergs, A., Schultzberg, M., Lerner, U.H., (1998) Acta Physiol. Scand, 134 (3), pp. 451-462; 
Amano, S., Arai, M., Goto, S., Togari, A., (2007) Biochim. Biophys. Acta, 1770 (6), pp. 966-973; 
Baldock, P.A., Allison, S.J., Lundberg, P., Lee, N.J., Slack, K., Lin, E.J., Enriquez, R.F., Herzog, H., (2007) J. Biol. Chem, 282 (26), pp. 19092-19102
},
	month = {2009///},
	pages = {9 - 19},
	abstract = {Neuropeptide (NPY) is a neurotransmitter widely distributed in central and peripheral nervous system that has been implicated in several physiological processes through activation of five different Y receptors: Y1, Y2, Y4, Y5, and y6. NPY system has been extensively studied for the last decades due to its implications in a wide variety of physiological processes. For this purpose a diversity of sophisticated animal models and receptors agonists and antagonists has been developed to better understand its actions throughout body homeostasis. Consequently, NPY and its receptors have recently emerged as a potential regulator of bone homeostasis. This is supported by the demonstration of an increase of bone mass in mice lacking Y1 or Y2 receptor genes. Recent findings revealed Y1 receptor as a potential drug target candidate for prevention and treatment of bone loss. Indeed, it has been demonstrated that osteoblasts express Y1 receptor while no other Y receptor was detected in these cells, implicating Y1 receptor signalling in the local control of bone turnover. In this review, we have summarized the findings obtained from studies on NPY system in skeletogenesis focusing on Y1 receptor. {\textcopyright} 2009 Bentham Science Publishers Ltd.},
	keywords = {1 [1 [3 [(3 piperidyl)]]propyl] 2 [[(4 chlorophenoxyl)methyl]indol 3 yl] 2 (4 piperidylpiperidyl)ethan 1 one, 2 [1 (3 chloro 5 isopropoxycarbonylaminophenyl)ethylamino] 6 [2 (5 ethyl 4 methyl 2 thiazolyl)ethyl] 4 morpholinopyridine, 2 [1 (3 chloro 5 isopropyloxycarbonylaminophenyl)ethylamino] 6 [2 (5 ethyl 4 methyl 1,3 thiazol 2 yl)ethyl] 4 morpholinopyridine, Amino Acid Sequence, animal, Animals, bone development, bone mass, bone remodeling, Bone remodelling, bone turnover, Brain, drug antagonism, drug effect, drug potentiation, drug targeting, genetics, gi 264879a, gr 231118, Homeostasis, human, Humans, ligand, Ligands, ly 357897, metabolism, molecular genetics, Molecular Sequence Data, n alpha [3,3 bis(1 naphthyl)propionyl]dextro arginine n [1 benzyl 2 methoxyethyl]amide, n [1 [4 [[[[4 [(dimethylamino)methyl]cyclohexyl]methyl]amino]iminomethyl]benzyl] 2 oxo 2 (1 pyrrolidinyl)ethyl] alpha [(2 naphthalenylsulfonyl)amino]benzenepropanamide, n2 diphenylacetyl n (4 ureidomethylbenzyl)argininamide, nalpha (diphenylacetyl) n (4 hydroxybenzyl) dextro argininamide, neuropeptide Y, neuropeptide Y receptor, neuropeptide Y receptor agonist, neuropeptide Y receptor antagonist, neuropeptide Y [25 dextro arginine], neuropeptide Y [26 dextro histidine], neuropeptide Y [31 leucine 34 proline], neuropeptide Y [6 arginine 34 proline], neuropeptide Y [7 phenylalanine 34 proline], neuropeptide Y1 receptor, neuropeptide Y2 receptor, neuropeptide Y4 receptor, neuropeptide Y5 receptor, neuropeptide Y6 receptor, nonhuman, osteoblast, osteoclast, osteolysis, peptide YY, peptide YY [31 leucine 34 proline], peptide YY [34 proline], pharmacological blocking, physiology, protein binding, protein expression, protein family, protein isolation, receptor intrinsic activity, Receptors, Neuropeptide Y, review, signal transduction, unclassified drug, Y1 receptor},
	isbn = {13894501 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-63049117952\&partnerID=40\&md5=2e70b182cba78971a24c5a8124b7799b},
	author = {Sousa, D.M. and Herzog, H. and Lamghari, M.}
}
